Magellan Health, the US healthcare company, has named Darren Lehrich as chief investor relations officer.
Lehrich joins from American Renal Associates, another US healthcare firm, where he served as senior vice president of strategy and IR over a five-year period. During that time, he helped set up the IR department ahead of the company’s 2016 IPO.
Prior to that, Lehrich held senior positions as a sell-side analyst covering the healthcare industry. For more than 10 years, he worked at Deutsche Bank where he was a managing director in equity research. He also held analyst positions at Piper Jaffray, SunTrust Robinson Humphrey and Furman Selz.
‘Darren is a highly respected leader who brings a solid track record in investor relations to Magellan,’ says Ken Fasola, Magellan Health’s CEO, in a statement.
‘He will be instrumental in collaborating with the executive leadership team to drive a dialogue that strengthens stakeholder understanding of the company’s goal to become a leading independent payer-services partner, offering comprehensive and integrated complex care services, solutions and insights across behavioral health, specialty health and pharmacy.’
Lehrich succeeds Joe Bogdan, who will continue to run the actuarial and underwriting team at Magellan as well as taking on new duties in the medical economics and analytics business unit, adds the statement.
